Classifications

• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B5/00—Measuring for diagnostic purposes; Identification of persons
  • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
  • A61B5/7271—Specific aspects of physiological measurement analysis
  • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
• • G—PHYSICS
  • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
  • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
  • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
  • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
  • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
  • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
  • G01N2333/4701—Details
  • G01N2333/4703—Regulators; Modulating activity
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
  • G01N2333/475—Assays involving growth factors
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
  • G01N2333/52—Assays involving cytokines
  • G01N2333/54—Interleukins [IL]
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
  • G01N2333/775—Apolipopeptides
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
  • G01N2333/81—Protease inhibitors
  • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
  • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/24—Immunology or allergic disorders
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/34—Genitourinary disorders
  • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Molecular Biology (AREA)
• Chemical & Material Sciences (AREA)
• Urology & Nephrology (AREA)
• Hematology (AREA)
• Immunology (AREA)
• Pathology (AREA)
• General Health & Medical Sciences (AREA)
• Physics & Mathematics (AREA)
• Public Health (AREA)
• Medical Informatics (AREA)
• Analytical Chemistry (AREA)
• Medicinal Chemistry (AREA)
• Food Science & Technology (AREA)
• Biochemistry (AREA)
• Biotechnology (AREA)
• General Physics & Mathematics (AREA)
• Microbiology (AREA)
• Cell Biology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Primary Health Care (AREA)
• Databases & Information Systems (AREA)
• Epidemiology (AREA)
• Data Mining & Analysis (AREA)
• Biophysics (AREA)
• Surgery (AREA)
• Physiology (AREA)
• Psychiatry (AREA)
• Signal Processing (AREA)
• Artificial Intelligence (AREA)
• Heart & Thoracic Surgery (AREA)
• Computer Vision & Pattern Recognition (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Investigating Or Analysing Biological Materials (AREA)
• Measuring And Recording Apparatus For Diagnosis (AREA)
• Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=49885245

Family Applications (1)

Country Status (20)

Families Citing this family (7)

Family Cites Families (11)

• 2013
  • 2013-12-18 MX MX2015008108A patent/MX2015008108A/es unknown
  • 2013-12-18 CN CN201380067553.2A patent/CN104871004A/zh active Pending
  • 2013-12-18 CA CA2895096A patent/CA2895096A1/en not_active Abandoned
  • 2013-12-18 JP JP2015548539A patent/JP6416778B2/ja not_active Expired - Fee Related
  • 2013-12-18 US US14/653,630 patent/US20150309052A1/en not_active Abandoned
  • 2013-12-18 RU RU2015129496A patent/RU2015129496A/ru not_active Application Discontinuation
  • 2013-12-18 SG SG11201504329RA patent/SG11201504329RA/en unknown
  • 2013-12-18 AU AU2013360685A patent/AU2013360685A1/en not_active Abandoned
  • 2013-12-18 HK HK15110600.4A patent/HK1209838A1/xx unknown
  • 2013-12-18 BR BR112015014232A patent/BR112015014232A2/pt not_active IP Right Cessation
  • 2013-12-18 WO PCT/EP2013/077253 patent/WO2014096110A1/en not_active Ceased
  • 2013-12-18 KR KR1020157018992A patent/KR20150096728A/ko not_active Withdrawn
  • 2013-12-18 EP EP13814523.0A patent/EP2936160A1/en not_active Withdrawn
  • 2013-12-18 MA MA38171A patent/MA38171B1/fr unknown
  • 2013-12-18 AR ARP130104857A patent/AR094118A1/es unknown
  • 2013-12-19 TW TW102147264A patent/TW201430347A/zh unknown
• 2015
  • 2015-06-09 TN TNP2015000263A patent/TN2015000263A1/fr unknown
  • 2015-06-15 IL IL239431A patent/IL239431A0/en unknown
  • 2015-06-18 PH PH12015501399A patent/PH12015501399A1/en unknown
  • 2015-06-19 CL CL2015001768A patent/CL2015001768A1/es unknown
• 2017
  • 2017-09-20 AU AU2017232081A patent/AU2017232081A1/en not_active Abandoned
• 2018
  • 2018-10-04 JP JP2018189053A patent/JP2019053067A/ja active Pending

Also Published As

Similar Documents